Altimmune Inc (NASDAQ: ALT) on Friday, plunged -2.53% from the previous trading day, before settling in for the closing price of $6.33. Within the past 52 weeks, ALT’s price has moved between $2.09 and $14.84.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 115.21%. The company achieved an average annual earnings per share of 16.61%. With a float of $70.34 million, this company’s outstanding shares have now reached $70.68 million.
Let’s determine the extent of company efficiency that accounts for 59 employees.
Altimmune Inc (ALT) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Altimmune Inc is 0.80%, while institutional ownership is 57.35%. The most recent insider transaction that took place on Aug 15 ’23, was worth 862. In this transaction Director of this company bought 300 shares at a rate of $2.88, taking the stock ownership to the 29,785 shares.
Altimmune Inc (ALT) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.37 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 16.61% per share during the next fiscal year.
Altimmune Inc (NASDAQ: ALT) Trading Performance Indicators
Altimmune Inc (ALT) is currently performing well based on its current performance indicators. A quick ratio of 11.30 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1066.96.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.62, a number that is poised to hit -0.36 in the next quarter and is forecasted to reach -1.52 in one year’s time.
Technical Analysis of Altimmune Inc (ALT)
Looking closely at Altimmune Inc (NASDAQ: ALT), its last 5-days average volume was 3.19 million, which is a drop from its year-to-date volume of 4.44 million. As of the previous 9 days, the stock’s Stochastic %D was 45.35%. Additionally, its Average True Range was 0.59.
During the past 100 days, Altimmune Inc’s (ALT) raw stochastic average was set at 15.61%, which indicates a significant decrease from 47.99% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 81.25% in the past 14 days, which was lower than the 87.08% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.67, while its 200-day Moving Average is $7.51. However, in the short run, Altimmune Inc’s stock first resistance to watch stands at $6.51. Second resistance stands at $6.85. The third major resistance level sits at $7.10. If the price goes on to break the first support level at $5.92, it is likely to go to the next support level at $5.67. Now, if the price goes above the second support level, the third support stands at $5.33.
Altimmune Inc (NASDAQ: ALT) Key Stats
Market capitalization of the company is 437.45 million based on 70,902K outstanding shares. Right now, sales total 430 K and income totals -88,450 K. The company made 10 K in profit during its latest quarter, and -24,390 K in sales during its previous quarter.
